Home / About Barrow Neurological Institute / News & Articles / As Seen In / Ivy Brain Tumor Center Announces Phase 0/2 Clinical Readout of Niraparib
Ivy Brain Tumor Center Announces Phase 0/2 Clinical Readout of Niraparib
Indicates significant improvement in overall survival of newly diagnosed glioblastoma patients.